DSCSA: What it Means for SurgiMac

• July 29 2023, by SurgiMac LLC
• 2 min reading time

The Drug Supply Chain Security Act (DSCSA) is a federal law that aims to enhance the traceability of prescription drugs in the United States. The law has specific requirements for wholesale distributors and dispensers, such as SurgiMac. These requirements are designed to help prevent counterfeit and diverted drugs from entering the supply chain.

For SurgiMac, the DSCSA means that they will need to implement a number of new processes and procedures. These include:

• Implementing a serialization system that tracks the unique identity of each prescription drug product
• Sharing serialization data with trading partners throughout the supply chain
• Implementing electronic pedigrees that document the movement of prescription drugs
• Conducting regular audits to ensure compliance with the DSCSA

SurgiMac is committed to complying with the DSCSA and ensuring the safety of the pharmaceutical products they supply to their medical and dental customers. They are working with their trading partners to implement the necessary processes and procedures, and they are confident that they will be able to meet the requirements of the law.

The implementation of the DSCSA is a significant undertaking, but it is one that is necessary to protect patients from counterfeit and diverted drugs. SurgiMac is proud to be a part of this effort, and they are confident that the DSCSA will make the pharmaceutical supply chain safer for everyone.

Here are some specific examples of how the DSCSA will impact SurgiMac's sales and distribution of pharmaceutical products:

• SurgiMac will need to collect serialization data from manufacturers and track the unique identity of each prescription drug product throughout the supply chain.
• SurgiMac will need to share serialization data with trading partners, such as pharmacies and hospitals.
• SurgiMac will need to implement electronic pedigrees that document the movement of prescription drugs.
• SurgiMac will need to conduct regular audits to ensure compliance with the DSCSA.

These changes will require SurgiMac to make some adjustments to their business processes. However, SurgiMac is committed to complying with the DSCSA and ensuring the safety of the pharmaceutical products they supply to their customers.

The DSCSA is a complex law, but it is an important step in protecting patients from counterfeit and diverted drugs. SurgiMac is committed to complying with the DSCSA and ensuring the safety of the pharmaceutical products they supply to their customers.

Tags

FDA Pharmaceutical

• Share on:
• WhatsApp
• Deel
• Tweet
• Pin it
• Messenger
• Email

---